Nucleic acidbased vaccine an overview sciencedirect. Vical to manufacture dna vaccines for advanced development. Vicl announced today that the company will present a summary of phase 2 data for the companys transvax therapeutic. Clinical development of a cytomegalovirus dna vaccine. A dna based vaccine against avian influenza can safely stimulate the immune system to levels expected to protect against flu, san diegobased vical inc reported on thursday. Cidrap news federal officials say a new west nile virus wnv vaccine for horses, licensed this week, represents a breakthrough that may lead to important benefits for human vaccine development.
Prospects for control of emerging infectious diseases with. Dna vaccination is a technique for protecting against disease by injection with genetically engineered plasmid containing the dna sequence encoding the antigens against which an immune response is sought so cells directly produce an antibody, producing a protective immunological response. Influenza vaccine may be given at the same time as other vaccines. Seattle, may 19, 2011 globe newswire vical incorporated nasdaq. Almost 20 years ago, malone and felgner at vical incorporated, and wolff and colleagues at the university of wisconsin, demonstrated that mrna and closed loops of doublestranded dna plasmids injected into muscle tissue could be taken up by cells at the administration site transfection resulting in the production expression of proteins not normally made by the. Examples of particular herpes research include drug development, vaccines and genome editing. A novel therapeutic cytomegalovirus dna vaccine in. Vical s therapeutic hsv2 dna vaccine tcell responses are the strength of dna technology cmv dna vaccine showed robust tcell responses reduced viremia in transplant patients in phase 2 trial collaboration with fred hutchinson cancer research center and university of washington uw. Vclcb01, an injectable bivalent plasmid dna vaccine for. Astellas and vical announce topline results for phase 3 trial of cytomegalovirus vaccine asp01 in hematopoietic stem cell transplant recipients.
Vical has proposed further development of the trivalent dna vaccine as a platform for immunisation against congenital cmv infection, but the current state of this vaccine in clinical development. A dna vaccine uses a gene from a virus or bacteria to stimulate the immune system. A cytomegalovirus dna vaccine induces antibodies that. Vical incorporated opens phase 2 trial of dna vaccine. Vaxfectin is a novel, secondgeneration, cationic lipidbased adjuvant optimized by vical to increase the immune response in dna vaccines. The vaccine comprises a plasmid, encoding the premembrane and envelope genes of all four dengue virus serotypes den1234. Vical was developing a monovalent cytomegalovirus cmv dna vaccine, vcl 6365 cymvectin, as a prophylactic immunotherapy to prevent congenital infections of vcl 6365 adisinsight either you have javascript disabled or your browser does not support javascript. West nile shot for horses is first licensed dna vaccine. Another method to improve dna vaccine immunogenicity is the inclusion of additional plasmids, or additional inserts in the same plasmid, encoding molecular adjuvants. First, a vaccine consisting of synthetic peptides derived from hsv2 complexed with heat shock protein 70 in saponin adjuvant elicited virusspecific hsv2 cd4 and cd8 t cells in a phase 1 trial. About vical vical researches and develops biopharmaceutical products based on its patented dna delivery technologies for the prevention and treatment of serious or lifethreatening diseases. A dna vaccine for the prevention of ebola virus infection. Pregnancy and h1n1, oseltamivir for hospitalized children, h1n1 dna vaccine. We randomly allocated participants in both parallel groups in a 1.
The centers for disease control and prevention cdc said the vaccine is the worlds first licensed dna vaccine one that uses small pieces of the target viruss genetic material instead of using. A similar vaccine comprised of recombinant gb protein adjuvanted with as01 has been developed by glaxosmithkline. Samant, vical s president and chief executive officer. Vicl said on thursday it has agreed to manufacture plasmid dna pdna vaccines against hiv under a usd2. Dna vaccines, which have a good safety profile, are well tolerated by the patients, and without any evident adverse events. Asp01 is a bivalent dna vaccine encoding cmv phosphoprotein 65 and glycoprotein b antigens for induction of both cellular and humoral immune responses, formulated with a proprietary poloxamerbased delivery system. Vical says dna flu vaccine formulated quickly the pharmaceutical company vical formulated an adjuvanted dna based vaccine against h1n1 influenza more rapidly than any of the companies relying on chicken eggs or cellculture techniques, and demonstrated its immunogenicity in mice and rabbits, according to an article inl gene therapy and. An influenza dna vaccine formulated in the lipid compound vaxfectin vical induced protective antibody titers and tcell responses in many subjects. When the dna vaccine is administered to a patient, the machinery in their cells makes a viral or bacterial protein which their immune system.
Vical dna h1n1 vaccine shows promise in early trial vical, a vaccine company based in san diego, today announced promising phase 1 clinical trial results for a dna based 2009 h1n1 vaccine that contains vaxfectin, its proprietary adjuvant. Has had an allergic reaction after a previous dose of influenza vaccine, or. Herpes simplex research includes all medical research that attempts to prevent, treat, or cure herpes, as well as fundamental research about the nature of herpes. Vical presentations on transvaxtm and dna vaccines at. Hsv1 and hsv2 are commonly thought of as oral and genital herpes respectively, but other members in the herpes family include chickenpox.
Vical announces issuance of key naked dna vaccine patent. Since dna vaccines are easily designed and manufactured, they are easier to preserve them, and they are inexpensive, as one of the most desirable types of vaccine. Asp01 was initially developed by vical which partnered with astellas for further development and commercialization. In addition, chiron technologies has developed a strategy that combines the dna and vectored vaccine. Preliminary results from a phase ii study of herpv, a peptide vaccine with 32 peptides linked to heat shock protein hsp and qs21 adjuvant, showed a 15% decrease in viral shedding, which persisted up to 6 months after the initial vaccine series. The nih and vical inc are developing an intramuscular needlefree dna vaccine containing plasmids encoding the envelope glycoprotein of ebola virus ebov from the sudan and zaire strains, and the nucleoprotein of ebov zaire strain. Cytomegalovirus vaccines clinical infectious diseases. Although no dna vaccine has yet been licensed, the niaid has developed and is. We are pleased to add a new option to our selection of adjuvants for future dna vaccine applications, said vijay b. Biotechnology industry business biotechnology industries intellectual property genetic engineering pharmaceutical industry. A phase i clinical trial demonstrated a good safety profile, with most adverse events limited to the site of. Proofofconcept testing of the vaccine in a phase 2 trial has been completed and the vaccine is expected to enter a pivotal phase 3 trial sponsored by astellas pharma, incorporated hereafter. The dna vaccine is currently in phase i development in the us only.
In addition to the vclcb01 vaccine, vical are also developing cymvectin, a monovalent plasmid encoding gb hcmv dna vaccine formulated with the cationic lipidcolipid adjuvant vaxfectin vical inc, specifically for the prevention of congenital hcmv infection. Vical incorporated hereafter vical developed a cmv dna vaccine candidate utilizing the first two of these strategies. Vical s therapeutic hsv2 dna vaccine tcell responses are the strength of dna technology simulates live attenuated approach without safety issues cmv dna vaccine showed reduced viremia in transplant patients in phase 2 trial collaboration with fred hutchinson cancer research center and university of washington uw. Dna vaccines have potential advantages over conventional vaccines, including the ability to induce a. Vaxfectinformulated influenza dna vaccines encoding np.
Dna vaccines offer simple yet effective means of inducing. Vical said conventional vaccines using whole wnv are available for horses and some species of birds. Dna vaccines burst into the scientific limelight in the early 1990s. Astellas and vical announce topline results for phase 3. Vical, san diego, ca, usa or placebo before conditioning and at 1, 3, and 6 months after transplantation. Patent for herpes simplex dna vaccine san diego, dec. But developing a conventional human vaccine against wnv could take many years of development and testing to verify safety and effectiveness, the company said. The transvax vaccine was developed by vical for use as a therapeutic vaccine. Dna vaccine vical vclhb01 gd, ul46ul46 vaxfectin ii, therapeutic significant reduction in viral load.
Plasmid dna vaccines encoding np provided protection in mice in some studies11 but not others. Briefvical initiates phase 2 trial of hsv2 therapeutic. Sept 26 reuters vical vical announces initiation of a phase 2 trial of its hsv 2 therapeutic dna vaccine for genital herpes says companys cash. Vaccination is the most successful application of immunological principles to human health. Washington a dna based vaccine against avian influenza can safely stimulate the immune system to levels expected to protect against flu, san diegobased vical inc reported on thursday. Vical presents pandemic influenza vaccine results and. Vical incorporated opens phase 2 trial of dna vaccine against cmv read this article along with other careers information, tips and advice on biospace.
Clinical trial of west nile dna vaccine starts cidrap. The centers for disease control and prevention cdc said the vaccine is the worlds first licensed dna vaccine one that uses small pieces of the target viruss genetic material instead of using a. However, the vaccine utilizes vical s proprietary vaxfectin adjuvant, so commercialization would require a licensing agreement with vical. Herpes simplex virus hsv vaccine development update. Firm gets funds for work on avian flu dna vaccine cidrap. A phase 2 trial of this vaccine was recently completed. Vicl today announced the publication of a new article1 in a special dna vaccine issue of the journal vaccines detailing the development process from initial product concept to phase 3 trial initiation for asp01 transvax, vical s investigational therapeutic vaccine designed to control cytomegalovirus cmv in transplant recipients. Vaccination to reduce reactivation of herpes simplex virus.
266 102 170 741 1029 290 585 1005 338 900 751 400 1275 431 931 1379 390 484 773 557 1519 1049 582 1097 810 1519 1156 834 823 289 392 265 817 504 753 1181 1434 951 686 821